Table 1.
Characteristics of hyperthermia-induced seizures and neuronal in situ end labeling
| Treatment | Hyperthermic seizures (n = 51) | Hyperthermia + AED* (n = 14) | Normothermic controls (n = 24) |
|---|---|---|---|
| Maximal temperature (°C) | 42.22 ± 0.07 | 42.32 ± 0.17 | N/A |
| Seizure duration (min) | 19.13 ± 1.21 | 0 (n = 12); 2; <2 | None |
| Survival time (hr) | 1 | 4 | 8.5 | 20* | 48 |
|---|---|---|---|---|---|
| ISEL-labeled cells: | |||||
| ACE (n) | 0 (9) | 0.36 ± 0.24 (11) | 1.50 ± 0.48 (12) | 0.1 ± 0.1 (10) | 0.37 ± 0.25 (8) |
| Hippocampus (n) | 0 (9) | 0.40 ± 0.21 (11) | 1.15 ± 0.32 (13) | 0 (10) | 0.25 ± 0.25 (8) |
ACE, Central nucleus of the amygdala; AED, antiepileptic drug; ISEL, in situ end labeling; N/A, not applicable; (n) denotes number of sections. Animals (marked with *) had hyperthermic seizures twice totaling 60 ± 2 min (see text). Values are means ± SE.